Drug Profile
QRS 10 001
Alternative Names: LF 10 001Latest Information Update: 30 Mar 2001
Price :
$50
*
At a glance
- Originator Fournier Pharma
- Class
- Mechanism of Action Apolipoprotein A I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis; Coronary artery restenosis; Coronary disorders; Hypoalphalipoproteinaemia
Most Recent Events
- 30 Mar 2001 Discontinued-Preclinical for Atherosclerosis in Germany (Unknown route)
- 30 Mar 2001 Discontinued-Preclinical for Coronary artery restenosis in Germany (Unknown route)
- 30 Mar 2001 Discontinued-Preclinical for Coronary disorders in Germany (Unknown route)